Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1822 1
1843 1
1954 1
1964 1
1965 1
1967 1
1969 1
1970 1
1971 2
1972 1
1974 1
1975 3
1976 4
1977 4
1978 1
1980 3
1983 2
1985 1
1987 1
1988 1
1989 2
1990 3
1991 3
1992 2
1993 1
1994 4
1995 3
1997 3
1998 5
1999 1
2000 4
2001 2
2002 3
2003 3
2005 1
2006 3
2007 4
2008 5
2009 6
2010 7
2011 8
2012 4
2013 6
2014 12
2015 15
2016 14
2017 29
2018 25
2019 30
2020 45
2021 62
2022 48
2023 59
2024 74
2025 113
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

585 results

Results by year

Filters applied: . Clear all
Page 1
Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial.
Ryan DH, Lingvay I, Deanfield J, Kahn SE, Barros E, Burguera B, Colhoun HM, Cercato C, Dicker D, Horn DB, Hovingh GK, Jeppesen OK, Kokkinos A, Lincoff AM, Meyhöfer SM, Oral TK, Plutzky J, van Beek AP, Wilding JPH, Kushner RF. Ryan DH, et al. Nat Med. 2024 Jul;30(7):2049-2057. doi: 10.1038/s41591-024-02996-7. Epub 2024 May 13. Nat Med. 2024. PMID: 38740993 Free PMC article. Clinical Trial.
For each BMI category (<30, 30 to <35, 35 to <40 and 40 kg m(-)(2)) there were lower rates (events per 100 years of observation) of serious adverse events with semaglutide (43.23, 43.54, 51.07 and 47.06 for semaglutide and 50.48, 49.66, 52.73 and 60.85 for placebo …
For each BMI category (<30, 30 to <35, 35 to <40 and 40 kg m(-)(2)) there were lower rates (events per 100 years of observat …
M. levator ani in the rat: does it really lift the anus?
Poortmans A, Wyndaele JJ. Poortmans A, et al. Anat Rec. 1998 May;251(1):20-7. doi: 10.1002/(SICI)1097-0185(199805)251:1<20::AID-AR5>3.0.CO;2-I. Anat Rec. 1998. PMID: 9605216 Free article.
RESULTS: We found some degree of similarity between the M. pubococcygeus and M. iliococcygeus muscles in both species. The M. levator ani in the rat resembles in gross anatomy the M. puborectalis in man, but the insertion and function are differ …
RESULTS: We found some degree of similarity between the M. pubococcygeus and M. iliococcygeus muscles in both species. The …
Safety and tolerability of intravenous immunoglobulin in patients with active dermatomyositis: results from the randomised, placebo-controlled ProDERM study.
Aggarwal R, Schessl J, Charles-Schoeman C, Bata-Csörgő Z, Dimachkie MM, Griger Z, Moiseev S, Oddis CV, Schiopu E, Vencovský J, Beckmann I, Clodi E, Levine T; ProDERM investigators. Aggarwal R, et al. Arthritis Res Ther. 2024 Jan 17;26(1):27. doi: 10.1186/s13075-023-03232-2. Arthritis Res Ther. 2024. PMID: 38233885 Free PMC article. Clinical Trial.
Benchmarking ANI potentials as a rescoring function and screening FDA drugs for SARS-CoV-2 M(pro).
Zengin IN, Koca MS, Tayfuroglu O, Yildiz M, Kocak A. Zengin IN, et al. J Comput Aided Mol Des. 2024 Mar 27;38(1):15. doi: 10.1007/s10822-024-00554-4. J Comput Aided Mol Des. 2024. PMID: 38532176 Free PMC article.
Here, we introduce the use of ANI-ML potentials as a rescoring function in the host-guest interaction in molecular docking. ...Using a unique protocol in which docking by GOLD-PLP, rescoring by ANI-ML potentials and extensive MD simulations along with end state free …
Here, we introduce the use of ANI-ML potentials as a rescoring function in the host-guest interaction in molecular docking. ...Using …
Characterization of atypical Mycoplasma anserisalpingitidis strains.
Kovács ÁB, Wehmann E, Grózner D, Bali K, Nemesházi E, Hrivnák V, Morrow CJ, Bányai K, Kreizinger Z, Gyuranecz M. Kovács ÁB, et al. Vet Microbiol. 2023 May;280:109722. doi: 10.1016/j.vetmic.2023.109722. Epub 2023 Mar 11. Vet Microbiol. 2023. PMID: 36940525 Free article.
The atypical strains showed notable genomic differences in all of the genetic analyses: on average ANI and AAI 95% (M. anserisalpingitidis ANI Minimum: 92.45, Maximum: 95.10; AAI Minimum: 93.34, Maximum: 96.37). The atypical strains formed a separate branch a …
The atypical strains showed notable genomic differences in all of the genetic analyses: on average ANI and AAI 95% (M. anseris …
CSF tau microtubule-binding region identifies pathological changes in primary tauopathies.
Horie K, Barthélemy NR, Spina S, VandeVrede L, He Y, Paterson RW, Wright BA, Day GS, Davis AA, Karch CM, Seeley WW, Perrin RJ, Koppisetti RK, Shaikh F, Lago AL, Heuer HW, Ghoshal N, Gabelle A, Miller BL, Boxer AL, Bateman RJ, Sato C. Horie K, et al. Nat Med. 2022 Dec;28(12):2547-2554. doi: 10.1038/s41591-022-02075-9. Epub 2022 Nov 24. Nat Med. 2022. PMID: 36424467 Free PMC article.
Dr. M'Cormac on Prolapsus Ani.
[No authors listed] [No authors listed] West J Med Surg. 1843 Sep;8(3):231-232. West J Med Surg. 1843. PMID: 38208162 Free PMC article. No abstract available.
Primary mediastinal tumours.
al-Naaman YD, al-Ani MS, al-Omeri MM. al-Naaman YD, et al. Thorax. 1974 Jul;29(4):475-81. doi: 10.1136/thx.29.4.475. Thorax. 1974. PMID: 4604946 Free PMC article.
Al-Naaman, Y. D., Al-Ani, M. S., and Al-Omeri, M. M. (1974).Thorax, 29, 475-481. Primary mediastinal tumours. ...
Al-Naaman, Y. D., Al-Ani, M. S., and Al-Omeri, M. M. (1974).Thorax, 29, 475-481. Primary mediastinal tumours. .. …
585 results